Correlation Between Aeglea Bio and Summit Therapeutics

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Aeglea Bio and Summit Therapeutics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Aeglea Bio and Summit Therapeutics into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Aeglea Bio Therapeutics and Summit Therapeutics PLC, you can compare the effects of market volatilities on Aeglea Bio and Summit Therapeutics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Aeglea Bio with a short position of Summit Therapeutics. Check out your portfolio center. Please also check ongoing floating volatility patterns of Aeglea Bio and Summit Therapeutics.

Diversification Opportunities for Aeglea Bio and Summit Therapeutics

-0.11
  Correlation Coefficient

Good diversification

The 3 months correlation between Aeglea and Summit is -0.11. Overlapping area represents the amount of risk that can be diversified away by holding Aeglea Bio Therapeutics and Summit Therapeutics PLC in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Summit Therapeutics PLC and Aeglea Bio is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Aeglea Bio Therapeutics are associated (or correlated) with Summit Therapeutics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Summit Therapeutics PLC has no effect on the direction of Aeglea Bio i.e., Aeglea Bio and Summit Therapeutics go up and down completely randomly.

Pair Corralation between Aeglea Bio and Summit Therapeutics

If you would invest  59.00  in Aeglea Bio Therapeutics on August 30, 2024 and sell it today you would earn a total of  0.00  from holding Aeglea Bio Therapeutics or generate 0.0% return on investment over 90 days.
Time Period3 Months [change]
DirectionMoves Against 
StrengthInsignificant
Accuracy4.35%
ValuesDaily Returns

Aeglea Bio Therapeutics  vs.  Summit Therapeutics PLC

 Performance 
       Timeline  
Aeglea Bio Therapeutics 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Aeglea Bio Therapeutics has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of rather sound essential indicators, Aeglea Bio is not utilizing all of its potentials. The current stock price tumult, may contribute to shorter-term losses for the shareholders.
Summit Therapeutics PLC 

Risk-Adjusted Performance

8 of 100

 
Weak
 
Strong
OK
Compared to the overall equity markets, risk-adjusted returns on investments in Summit Therapeutics PLC are ranked lower than 8 (%) of all global equities and portfolios over the last 90 days. In spite of comparatively weak primary indicators, Summit Therapeutics unveiled solid returns over the last few months and may actually be approaching a breakup point.

Aeglea Bio and Summit Therapeutics Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Aeglea Bio and Summit Therapeutics

The main advantage of trading using opposite Aeglea Bio and Summit Therapeutics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Aeglea Bio position performs unexpectedly, Summit Therapeutics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Summit Therapeutics will offset losses from the drop in Summit Therapeutics' long position.
The idea behind Aeglea Bio Therapeutics and Summit Therapeutics PLC pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the FinTech Suite module to use AI to screen and filter profitable investment opportunities.

Other Complementary Tools

Portfolio Backtesting
Avoid under-diversification and over-optimization by backtesting your portfolios
Top Crypto Exchanges
Search and analyze digital assets across top global cryptocurrency exchanges
Positions Ratings
Determine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance
Alpha Finder
Use alpha and beta coefficients to find investment opportunities after accounting for the risk
Pair Correlation
Compare performance and examine fundamental relationship between any two equity instruments